Prognosis of Intrahepatic Cholangiocarcinomas with HBV Infection is Better than Those with Hepatolithiasis After R0 Liver Resection: A Propensity Score Matching Analysis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Annals of Surgical Oncology

• Publication date

  2017-01-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1245/s10434-016-5751-9PMID 28058554
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management.

  2016cited by this paper
• Outcomes after Resection of Intrahepatic Cholangiocarcinoma: External Validation and Comparison of Prognostic Models.

  2015cited by this paper
• Identification of Risk and Prognostic Factors for Patients with Clonorchiasis-Associated Intrahepatic Cholangiocarcinoma

  2014cited by this paper
• Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma.

  2014cited by this paper
• Diagnosis and Surgical Treatment of Intrahepatic Hepatolithiasis Combined with Cholangiocarcinoma

  2014cited by this paper
• Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.

  2013cited by this paper
• Expression Levels and Significance of Nuclear Factor-κB and Epidermal Growth Factor Receptor in Hepatolithiasis Associated with Intrahepatic Cholangiocarcinoma

  2013cited by this paper
• Characteristics of intrahepatic cholangiocarcinoma in patients with hepatitis B virus infection: clinicopathologic study of resected tumours

  2013cited by this paper
• Pathogenesis, diagnosis, and management of cholangiocarcinoma.

  2013cited by this paper
• Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy.

  2013cited by this paper
• Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma.

  2012cited by this paper
• Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes

  2012cited by this paper
• Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.

  2012cited by this paper
• Evaluation of Risk Factors and Clinicopathologic Features for Intrahepatic Cholangiocarcinoma in Southern China: A Possible Role of Hepatitis B Virus

  2011cited by this paper
• Hepatitis B virus x protein in the pathogenesis of hepatitis B virus‐induced hepatocellular carcinoma

  2011cited by this paper
• Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size

  2011cited by this paper
• The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

  2010cited by this paper
• Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case–control study in China

  2010cited by this paper
• Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis.

  2010cited by this paper
• Multiepitope peptide‐loaded virus‐like particles as a vaccine against hepatitis B virus–related hepatocellular carcinoma

  2009cited by this paper
• Diagnosis and management of cholangiocarcinoma

  2008cited by this paper
• Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China.

  2008cited by this paper
• Cholangiocarcinoma.

  2005cited by this paper
• Rare Outcomes, Common Treatments: Analytic Strategies Using Propensity Scores

  2002cited by this paper
• Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

  1998cited by this paper
• Hepatolithiasis associated with cholangiocarcinoma

  1997cited by this paper
• Reducing Bias in Observational Studies Using Subclassification on the Propensity Score

  1984cited by this paper

• Hepatitis Virus Infection Predicts Heterogeneous Enhancement Patterns in Intrahepatic Cholangiocarcinoma on Contrast‐Enhanced Ultrasound: A Retrospective Radiological Cohort Study

  2025cites this paper
• Serum high-density lipoprotein cholesterol levels predict early recurrence and prognosis of intrahepatic cholangiocarcinoma after surgical resection

  2024cites this paper
• Unveil Intrahepatic Cholangiocarcinoma Heterogeneity through the Lens of Omics and Multi-Omics Approaches

  2024cites this paper
• Introducing and Validating the Multiphasic Evidential Decision-Making Matrix (MedMax) for Clinical Management in Patients with Intrahepatic Cholangiocarcinoma

  2024cites this paper
• Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes

  2023influential citation
• MRI for Hepatitis B‐Associated Intrahepatic Cholangiocarcinoma: A Multicenter Comparative Study

  2023cites this paper
• A comparative study of clinicopathological and imaging features of HBV-negative and HBV-positive intrahepatic cholangiocarcinoma patients with different pathologic differentiation degrees

  2023cites this paper
• Postoperative Prognosis of Non-alcoholic Fatty Liver Disease-Associated Intrahepatic Cholangiocarcinoma: a Multi-center Propensity Score Matching Analysis

  2023cites this paper
• Perspective of tumor heterogeneity for treatments of intrahepatic cholangiocarcinoma with intrahepatic lithiasis

  2023cites this paper
• Evaluating prognostic value of biliary stone in intrahepatic cholangiocarcinoma by propensity score matching analysis

  2023cites this paper
• Long-term outcomes of anatomic vs. non-anatomic resection in intrahepatic cholangiocarcinoma with hepatolithiasis: A multicenter retrospective study

  2023cites this paper
• Liver Tumor Markers, HALP Score, and NLR: Simple, Cost-Effective, Easily Accessible Indexes for Predicting Prognosis in ICC Patients after Surgery

  2022cites this paper
• Linoleic acid pathway disturbance contributing to potential cancerization of intrahepatic bile duct stones into intrahepatic cholangiocarcinoma

  2022cites this paper
• Recurrence and prognosis in intrahepatic cholangiocarcinoma patients with different etiology after radical resection: a multi-institutional study

  2021influential citation
• A Nomogram in Predicting Risks of Intrahepatic Cholangiocarcinoma After Partial Hepatectomy for Hepatolithiasis

  2021cites this paper
• Liver Imaging and Data System (LI-RADS) Version 2018 and Other Imaging Features in Intrahepatic Cholangiocarcinoma in Chinese Adults with vs. without Chronic Hepatitis B Viral Infection

  2021cites this paper
• Update on the association of hepatitis B with intrahepatic cholangiocarcinoma: Is there new evidence?

  2021cites this paper
• Double-Negative α-Fetoprotein and Carbohydrate Antigen 19-9 Predict a Good Prognosis in Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis

  2021cites this paper
• Surgical Approach to Recurrent Cholangiocarcinoma.

  2020cites this paper
• Transarterial chemoembolization versus percutaneous microwave coagulation therapy for recurrent unresectable intrahepatic cholangiocarcinoma: Development of a prognostic nomogram.

  2020cites this paper
• Clinicopathological and prognostic implications of vessels encapsulate tumor clusters with PD-L1 in intrahepatic cholangiocarcinoma patients

  2020cites this paper
• Development and Validation of a Nomogram for Differentiating Combined Hepatocellular Cholangiocarcinoma From Intrahepatic Cholangiocarcinoma

  2020cites this paper
• High serum gamma-glutamyl transpeptidase concentration associates with poor postoperative prognosis of patients with hepatitis B virus-associated intrahepatic cholangiocarcinoma

  2020cites this paper
• Hepatitis B virus-Associated Intrahepatic Cholangiocarcinoma Has Distinct Clinical, Pathological and Radiological Characteristics: A Systematic Review

  2019influential citation
• Coming of a precision era of the staging systems for intrahepatic cholangiocarcinoma?

  2019cites this paper
• Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study

  2018cites this paper
• Improves Survival in patients with HBV infection and Intra-hepatic Cholangiocarcinoma undergoing Liver

  2018cites this paper
• Recurrent pyogenic cholangitis - an independent poor prognostic indicator for resectable intrahepatic cholangiocarcinoma: A propensity score matched analysis.

  2018cites this paper
• Impact of viral hepatitis B status on outcomes of intrahepatic cholangiocarcinoma: a meta-analysis

  2018cites this paper
• Prognostic implications of hepatitis B virus infection in intrahepatic cholangiocarcinoma treated with first-line gemcitabine plus cisplatin

  2018cites this paper
• Prognostic factors in patients with recurrent intrahepatic cholangiocarcinoma after curative resection: A retrospective cohort study.

  2018cites this paper
• Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection: Novel concerns.

  2018cites this paper
• Infection a Highly Selected Population for Liver Transplantation

  2017cites this paper
• Reply

  2017cites this paper
• Intrahepatic cholangiocarcinoma arising from HBV infection may be a highly selected population for liver transplantation

  2017cites this paper
• Transarterial Chemoembolization: A Favorable Postoperative Management to Improve Prognosis of Hepatitis B Virus-associated Intrahepatic Cholangiocarcinoma after Surgical Resection

  2017cites this paper
• Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection

  2017cites this paper
• Mesenchymal stem cells for hepatitis B patients with acute on chronic liver failure—are we there?

  2017cites this paper